Akebia Therapeutics Inc.

Akebia Therapeutics Inc. annual/quarterly operating income history and growth rate from 2014 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.

• Akebia Therapeutics Inc. operating income for the quarter ending March 31, 2026 was -4.7 M, a 134.75% decrease year-over-year.
• Akebia Therapeutics Inc. operating income for the twelve months ending March 31, 2026 was 27.4 M, a 155.60% decrease year-over-year.
• Akebia Therapeutics Inc. annual operating income for 2025 was 23.5 M, a 146.56% decrease from 2024.
• Akebia Therapeutics Inc. annual operating income for 2024 was -50.5 M, a 9.11% increase from 2023.
• Akebia Therapeutics Inc. annual operating income for 2023 was -46.3 M, a 42.74% decrease from 2022.
• Akebia Therapeutics Inc. annual operating income for 2022 was -80.8 M.